SteadyMed, developer of a hypertension drug and a discreet, pre-filled drug-delivery device to go with it, filed plans for an initial public offering worth as much as $55 million.
SteadyMed Therapeutics filed plans to pursue an initial public offering worth as much as $55 million, money that will help it launch hypertension and pain treatments delivered with a discrete, patented drug-delivery device.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1740M7c
Cap comentari:
Publica un comentari a l'entrada